Research & Development

FDA Expands Access to AVIM Therapy Trial for Pacemaker Patients
Research & Development FDA Expands Access to AVIM Therapy Trial for Pacemaker Patients

What if a small device in millions of chests across America could do more than regulate heartbeats—what if it could also tame the silent threat of high blood pressure? For countless older adults with pacemakers, uncontrolled hypertension remains a persistent danger, often resistant to standard

How Is T7-ORACLE Revolutionizing Protein Engineering?
Research & Development How Is T7-ORACLE Revolutionizing Protein Engineering?

What if the key to defeating devastating diseases like cancer or antibiotic-resistant infections could be unlocked in mere days instead of months or years, transforming the landscape of medical research? This isn't a distant dream but a tangible reality with a groundbreaking tool developed by

RNA Sequencing Breakthrough Boosts Regenerative Therapies
Research & Development RNA Sequencing Breakthrough Boosts Regenerative Therapies

Imagine a world where damaged tissues can be regenerated with pinpoint accuracy, where therapies are tailored to an individual’s unique genetic makeup, and where neurological disorders are treated by targeting the exact molecular missteps. This vision is becoming a reality thanks to a revolutionary

Can AI and Pharma Unite in a $6 Billion Breakthrough?
Research & Development Can AI and Pharma Unite in a $6 Billion Breakthrough?

The pharmaceutical industry finds itself at a historic crossroads, where the fusion of cutting-edge technology and medical science could redefine the future of drug discovery, promising faster and more efficient solutions. A monumental $6 billion partnership between XtalPi, a Chinese company

Unsweetened Tea Linked to Lower Mortality Risk in Study
Research & Development Unsweetened Tea Linked to Lower Mortality Risk in Study

In a remarkable exploration of dietary habits, a recent study published in Frontiers in Nutrition has revealed a significant connection between drinking unsweetened tea and a reduced risk of mortality from various causes, offering new insights into everyday health choices. Tea, a beloved beverage

Why Did Lilly's Obesity Pill Trial Disappoint Investors?
Research & Development Why Did Lilly's Obesity Pill Trial Disappoint Investors?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the pharmaceutical industry. Today, we’re diving into the latest developments surrounding obesity and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later